Edward J. Sitar - Apr 15, 2022 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role
Director
Signature
/s/ Joseph Lucchese, Power of Attorney
Stock symbol
TMBR
Transactions as of
Apr 15, 2022
Transactions value $
$0
Form type
4
Date filed
4/19/2022, 12:58 PM
Previous filing
Nov 24, 2021
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMBR Common Stock, par value $0.001 per share Award $0 +150K +1000% $0.00 165K Apr 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +150K $0.00 150K Apr 15, 2022 Common Stock, par value $0.001 per share 150K $0.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 15, 2022, the Reporting Person was granted 150,000 restricted stock units, which will be settled in shares of common stock, par value $0.001, of Timber Pharmaceuticals, Inc. (the "Issuer"). The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2022, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.
F2 Includes 150,000 restricted stock units that are unvested.
F3 25% of the options vest on April 15, 2023, and the remaining shares will become exercisable in 24 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date.